Omega-3 PUFA, received a positive recommendation in the Australian heart failure guidelines whereas all other nutraceuticals are inadequately studied to allow any conclusion on efficacy.
New research found taking omega-3 fatty acid supplements was associated with better brain function in people with coronary artery disease, which increases risk for dementia.
DPA shows comparable chemotherapy sensitizing effects as EPA upon cellular incorporation in tumor cells
Dietary supplementation with DPA omega-3 fatty acids has been reported to enhance the sensitivity of tumor cells towards chemotherapy.
Some studies have shown that omega-3 may be beneficial in treating people with depression and some psychiatric disorders.
The Influence of Omega-3 Fatty Acids on Skeletal Muscle Protein Turnover in Health, Disuse, and Disease
There are reports of clinically-relevant gains in muscle size and strength in healthy older persons with omega-3 fatty acid intake as well as evidence that omega-3 fatty acid ingestion alleviates the loss of muscle mass and prevents decrements in mitochondrial respiration during periods of muscle-disuse.
Randomized control trails found that 840mg/day of EPA and DHA significantly reduced risks of CHD and CV death, especially in people who do not consume seafood and fish frequently.
Study shows importance of prenatal omega-3 supplementation – a higher imbalance of high omega-6 to low omega-3 in the 2nd trimester shows this may be a risk factor for childhood atopic dermatitis.